FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Fentanyl Citrate (Sublimaze) Injection
Status: Currently in Shortage
»Date first posted: No date available
»Therapeutic Categories: Analgesia/Addiction; Pediatric

Expand all

Akorn Pharmaceuticals (Revised 11/21/2016)

Company Contact Information:
800-932-5676

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mL ampule 10 pack (NDC 17478-0030-02) Available Other
2 mL ampule; 25 pack (NDC 17478-0030-25) Available Other
5 mL ampule 10 pack (NDC 17478-0030-05) Available Other
20 mL ampule (NDC 17478-0030-20) Available Other
5 mL ampule 25 pack (NDC 17478-0030-55) Available Other

Hospira, Inc. (Revised 11/13/2017)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
0.05 mg/mL; 2 mL Carpuject (NDC 0409-1276-32) Next delivery: 3Q 2018; Estimated recovery: September 2018 Shortage per Manufacturer: Manufacturing Delay Other
0.05 mg/mL; 2 mL amp (NDC 0409-9093-32) Available Available Other
0.05 mg/mL; 5 mL amp (NDC 0409-9093-35) Next delivery: Early November 2017; Estimated recovery: March 2018 Shortage per Manufacturer: Manufacturing Delay Other
0.05 mg/mL; 20 mL amp (NDC 0409-9093-38) Next delivery & Estimated recovery: TBD Shortage per Manufacturer: Manufacturing Delay Other
0.05 mg/mL; 2 mL vial (NDC 0409-9094-22) Next delivery: Early November 2017; Estimated recovery: March 2018 Shortage per Manufacturer: Manufacturing Delay Other
0.05 mg/mL; 5 mL vial (NDC 0409-9094-25) Next delivery: Early November 2017; Estimated recovery: March 2018 Shortage per Manufacturer: Manufacturing Delay Other
0.05 mg/mL; 10 mL vial (NDC 0409-9094-28) Next delivery: Early November 2017; Estimated recovery: March 2018 Shortage per Manufacturer: Manufacturing Delay Other
0.05 mg/mL; 20 mL vial (NDC 0409-9094-31) Next delivery: Early December 2017; Estimated recovery: March 2018 Shortage per Manufacturer: Manufacturing Delay Other
0.05 mg/mL; 50 mL vial (NDC 0409-9094-61) Next delivery: Early November 2017; Estimated recovery: March 2018 Shortage per Manufacturer: Manufacturing Delay Other

West-Ward Pharmaceuticals (Revised 06/06/2017)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mcg/mL 2 mL ampul (NDC 0641-6024-10) This presentation is temporarily on backorder. Additional lots are scheduled to be manufactured in the July 2017 timeframe. Product will be made available as it is released. Demand increase for the drug
50 mcg/mL 5 mL ampul (NDC 0641-6025-10) This presentation is temporarily on backorder. Additional lots are scheduled to be manufactured in the July 2017 timeframe. Product will be made available as it is released. Demand increase for the drug
50 mcg/mL 20 mL ampul (NDC 0641-6026-05) This presentation is temporarily on backorder. Additional lots are scheduled to be manufactured in the July 2017 timeframe. Product will be made available as it is released. Demand increase for the drug
50 mcg/mL 2 mL vial (NDC 0641-6027-25) This presentation is temporarily on backorder. Additional lots are scheduled to be manufactured in the June - July 2017 timeframe. Product will be made available as it is released. Demand increase for the drug
50 mcg/mL 5 mL vial (NDC 0641-6028-25) This presentation is temporarily on backorder. Additional lots are scheduled to be manufactured in the July 2017 timeframe. Product will be made available as it is released. Regulatory delay
50 mcg/mL 20 mL vial (NDC 0641-6029-25) West-Ward has inventory available. Additional lots are scheduled to be manufactured in the July 2017 timeframe. Product will be made available as it is released. Demand increase for the drug
50 mcg/mL 50 mL vial (NDC 0641-6030-01) This presentation is temporarily on backorder. Additional lots are scheduled to be manufactured in the June - July 2017 timeframe. Product will be made available as it is released. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English